United States Department of Veterans Affairs
United States Department of Veterans Affairs
HIV/AIDS
Patients' Home > Treatment > Drug Dosing Toolkit > RescriptorEnlarge Text Size:Small Font SizeMedium Font SizeLarge Font Size

Drug Dosing Toolkit

Rescriptor (delavirdine)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."

Approved adult dosing

four 100 mg tablets, three times a day

  • Morning

    Rescriptor 100Rescriptor 100Rescriptor 100Rescriptor 100

    Rescriptor 100 mg

  • Mid-day

    Rescriptor 100Rescriptor 100Rescriptor 100Rescriptor 100

    Rescriptor 100 mg

  • Evening

    Rescriptor 100Rescriptor 100Rescriptor 100Rescriptor 100

    Rescriptor 100 mg

two 200 mg tablets, three times a day

  • Morning

    Rescriptor 200Rescriptor 200

    Rescriptor 200 mg

  • Mid-day

    Rescriptor 200Rescriptor 200

    Rescriptor 200 mg

  • Evening

    Rescriptor 200Rescriptor 200

    Rescriptor 200 mg

Notes on taking this medication

  • No food restrictions, can take with or without food
  • Rescriptor interacts with many other drugs; persons using Rescriptor with those drugs may need an adjustment to their dose of Rescriptor or the other drugs; consult your medical provider

Side effects

  • Rash (usually occurs within first 3 weeks of starting drug)
  • Liver inflammation and increased liver enzyme levels
  • Headache; fatigue; stomach upset

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Disclaimer:

This information is not meant to substitute for advice from your medical provider or pharmacist. If you have any questions about your medication dosing, talk to your medical provider or pharmacist.

Image of Rescriptor is courtesy of T. Van Nunnery

iconPrint this page
iconEmail this page

ContentsScroll over drug name to see other names for the drug.

Aptivus
Atripla
AZT (Retrovir)
Combivir
Crixivan
Emtriva
Epivir
Epzicom
Fuzeon
Intelence
Invirase
Isentress
Kaletra
Lexiva
Norvir
Prezista
Rescriptor
Reyataz
Selzentry
Sustiva
Trizivir
Truvada
Videx EC
Viracept
Viramune
Viread
Zerit
Ziagen
Tips for Common Side Effects

* Indicates a link that will take you outside the Department of Veterans Affairs website.
** Indicates a non-U.S. government website; VA does not endorse and is not responsible for the content of the linked site.

HIV/AIDS is a part of the Office of Public Health and Environmental Hazards.

OPHEH | Public Health | Emergency Management| Employee Safety and Health
Hazardous Exposures | Environmental Epidemiology | Women Veterans Health Care